These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 3683038

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Postoperative chemoradiotherapy for high-risk head-and-neck squamous cell carcinoma.
    Porceddu SV, Campbell B, Rischin D, Corry J, Weih L, Guerrieri M, Grossi M, Peters LJ.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):365-73. PubMed ID: 15380568
    [Abstract] [Full Text] [Related]

  • 3. Simultaneous radio- and chemotherapy for squamous cell carcinoma of the head and neck in daily clinical practice: 5 years experience in a University Hospital.
    Langenberg M, Terhaard CH, Hordijk GJ, Es RJ, Voest EE, Graeff A.
    Clin Otolaryngol Allied Sci; 2004 Dec 01; 29(6):729-34. PubMed ID: 15533169
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Concomitant administration of two standard regimens of chemotherapy and radiotherapy in advanced squamous carcinoma of the head and neck: a feasibility study.
    Benasso M, Corvò R, Numico G, Cavallari M, Blengio F, Sanguineti G, Rosso M, Merlano M.
    Anticancer Res; 1995 Dec 01; 15(6B):2651-4. PubMed ID: 8669841
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cisplatin as a radiosensitizer in the treatment of locally advanced head and neck cancer.
    Altundag O, Altundag K, Morandi P, Hanrahan E.
    Oral Oncol; 2005 Apr 01; 41(4):435. PubMed ID: 15792617
    [No Abstract] [Full Text] [Related]

  • 9. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer.
    Machtay M, Rosenthal DI, Chalian AA, Lustig R, Hershock D, Miller L, Weinstein GS, Weber RS.
    Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):72-7. PubMed ID: 15093901
    [Abstract] [Full Text] [Related]

  • 10. Multimodality therapy of patients with locally advanced squamous cell cancer of the head and neck: preliminary results of two pilot trials using paclitaxel and cisplatin.
    Flood W, Lee DJ, Trotti A, Spencer S, Murphy B, Khuri F, DeConti R, Wheeler R, Forastiere AA.
    Semin Radiat Oncol; 1999 Apr 01; 9(2 Suppl 1):64-9. PubMed ID: 10210542
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
    Chang PM, Chen PM, Chu PY, Wang LW, Tai SK, Tsai TL, Huang JL, Wang YF, Chang SY, Yang MH.
    Cancer Chemother Pharmacol; 2008 Dec 01; 63(1):9-17. PubMed ID: 18343925
    [Abstract] [Full Text] [Related]

  • 12. Impact of adding concomitant chemotherapy to hyperfractionated accelerated radiotherapy for advanced head-and-neck squamous cell carcinoma.
    Nuyts S, Dirix P, Clement PM, Poorten VV, Delaere P, Schoenaers J, Hermans R, Van den Bogaert W.
    Int J Radiat Oncol Biol Phys; 2009 Mar 15; 73(4):1088-95. PubMed ID: 18707823
    [Abstract] [Full Text] [Related]

  • 13. Carboplatin and radiotherapy in the treatment of head and neck cancer: six years' experience.
    Zamboglou N, Schnabel T, Kolotas C, Achterrath W, Strehl H, Dalhäuser S, Vogt HG, Lenaz L, Schmitt G.
    Semin Oncol; 1994 Oct 15; 21(5 Suppl 12):45-53. PubMed ID: 7992066
    [Abstract] [Full Text] [Related]

  • 14. Comparative study of efficacy and toxicities of cisplatin vs vinorelbine as radiosensitisers in locally advanced head and neck cancer.
    Sarkar SK, Patra NB, Goswami J, Basu S.
    J Laryngol Otol; 2008 Feb 15; 122(2):188-92. PubMed ID: 17445333
    [Abstract] [Full Text] [Related]

  • 15. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A, Morris M, Schmidt-Ullrich R, Wu Q, Mohan R, Abayomi O, Buck D, Holdford D, Dawson K, Dinardo L, Reiter E.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):374-87. PubMed ID: 15380569
    [Abstract] [Full Text] [Related]

  • 16. Normobaric oxygen as a sensitizer in radiotherapy for advanced head and neck cancer.
    Zajusz A, Maciejewski B, Hliniak A.
    Neoplasma; 1995 Oct 01; 42(3):137-40. PubMed ID: 7637824
    [Abstract] [Full Text] [Related]

  • 17. Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck.
    Leonard CE, Chan DC, Chou TC, Kumar R, Bunn PA.
    Cancer Res; 1996 Nov 15; 56(22):5198-204. PubMed ID: 8912857
    [Abstract] [Full Text] [Related]

  • 18. Neoadjuvant accelerated chemotherapy followed by hyperfractionated radiation therapy in patients with operable, locally advanced head and neck carcinoma.
    Franchin G, Vaccher E, Gobitti C, Minatel E, Politi D, Talamini R, Di Gennaro G, Savignano G, Trovò MG, Tirelli U, Barzan L.
    Oral Oncol; 2005 May 15; 41(5):526-33. PubMed ID: 15878759
    [Abstract] [Full Text] [Related]

  • 19. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Katori H, Tsukuda M, Taguchi T.
    Cancer Chemother Pharmacol; 2007 May 15; 59(6):789-94. PubMed ID: 17053926
    [Abstract] [Full Text] [Related]

  • 20. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
    Papadimitrakopoulou VA, Dimery IW, Lee JJ, Perez C, Hong WK, Lippman SM.
    Cancer J Sci Am; 1997 May 15; 3(2):92-9. PubMed ID: 9099459
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.